Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
18 Leser
Artikel bewerten:
(0)

BioMed Realty Trust Revises Announcement of Tax Treatment of 2008 Distributions

SAN DIEGO, Jan. 30 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. today amended its news release "BioMed Realty Trust Announces Tax Treatment of 2008 Distributions" issued January 20, 2009 with respect to the Taxable Ordinary Dividend and Return of Capital distributions for the four quarterly dividends displayed in the Common Stock table. The amended version of the distribution tables and information follows:

Security Description: Common Stock CUSIP: 09063H107 Ticker Symbol: BMR Total Taxable Record Payable Distribution Allocable Ordinary Date Date Per Share to 2008 Dividend 12/31/2007 1/15/2008 $0.310000 $0.310000 $0.255350 3/31/2008 4/15/2008 $0.335000 $0.335000 $0.275942 6/30/2008 7/15/2008 $0.335000 $0.335000 $0.275942 9/30/2008 10/15/2008 $0.335000 $0.335000 $0.275942 Totals $1.315000 $1.315000 $1.083176 Long-Term Unrecaptured Record Payable Return of Capital Section 1250 Date Date Capital Gain Gain 12/31/2007 1/15/2008 $0.054650 $0.000000 $0.000000 3/31/2008 4/15/2008 $0.059058 $0.000000 $0.000000 6/30/2008 7/15/2008 $0.059058 $0.000000 $0.000000 9/30/2008 10/15/2008 $0.059058 $0.000000 $0.000000 Totals $0.231824 $0.000000 $0.000000 Security Description: 7.375% Series A Cumulative Redeemable Preferred Stock CUSIP: 09063H206 Ticker Symbol: BMR PR A Total Taxable Record Payable Distribution Allocable Ordinary Date Date Per Share to 2008 Dividend 12/31/2007 1/15/2008 $0.460940 $0.460940 $0.460940 3/31/2008 4/15/2008 $0.460940 $0.460940 $0.460940 6/30/2008 7/15/2008 $0.460940 $0.460940 $0.460940 9/30/2008 10/15/2008 $0.460940 $0.460940 $0.460940 Totals $1.843760 $1.843760 $1.843760 Long-Term Unrecaptured Record Payable Return of Capital Section 1250 Date Date Capital Gain Gain 12/31/2007 1/15/2008 $0.000000 $0.000000 $0.000000 3/31/2008 4/15/2008 $0.000000 $0.000000 $0.000000 6/30/2008 7/15/2008 $0.000000 $0.000000 $0.000000 9/30/2008 10/15/2008 $0.000000 $0.000000 $0.000000 Totals $0.000000 $0.000000 $0.000000

The distributions payable on January 15, 2009 to shareholders of record on December 31, 2008, as previously announced on December 15, 2008, are considered 2009 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2008. In addition, only for purposes of calculating alternative minimum taxable income under Section 55 of the Internal Revenue Code of 1986, as amended, the company apportions $0.0009 per common share and Series A preferred share attributable to depreciation, each assuming a full year of ownership. Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 69 properties, representing 112 buildings with approximately 10.4 million rentable square feet, including approximately 1.4 million square feet of development in progress. The company also owns undeveloped land parcels adjacent to existing properties that it estimates can support up to 1.4 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at http://www.biomedrealty.com/.

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.